Patent details

Basic Information

Publication number:

EP2897589

PCT Application Number:

US2014066840

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148095706

PCT Publication Number:

WO2015077574

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

AN INHALABLE MEDICAMENT

French Title of Invention:

MÉDICAMENT INHALABLE

German Title of Invention:

INHALIERBARES MEDIKAMENT

SPC Number:

Dates

Filing date:

21/11/2014

Grant date:

03/01/2018

EP Publication Date:

29/07/2015

PCT Publication Date:

28/05/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/01/2018

EP B1 Publication Date:

03/01/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/11/2018

Expiration date:

21/11/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/12/2017

 

 

Name:

Teva Branded Pharmaceutical Products R & D, Inc.

Address:

41 Moores Road, Frazer, PA 19355, United States (US)

Inventor

1

Name:

DALVI, Mukul

Address:

United States (US)

2

Name:

WU, Libo

Address:

United States (US)

Priority

Priority Number:

201361907778 P

Priority Date:

22/11/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 9/08; A61K 31/46; A61K 47/02; A61K 47/06; A61K 47/12; A61M 11/00; A61M 15/00; A61K 47/10;

Publication

European Patent Bulletin

Issue number:

201801

Publication date:

03/01/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/03/2019	Outgoing Correspondence	1